brain cancer research

Investment in Agios Pharmaceuticals

Investment in Agios Pharmaceuticals

Accelerate Brain Cancer Cure's investment enables Agios, a Boston based biopharmaceutical company, to explore whether the mutated IDH1 gene has an enzyme activity consistent with a cancer-causing gene, or oncogene.
Press Release

1 2 3
Get the ABC2 E-newsletter Follow us on Twitter (show in-page feed) Follow us on Facebook

Our Approach

to finding a cure for brain cancer

Accelerate Brain Cancer Cure (ABC2) believes that a nimble, focused and aggressive entrepreneurial model will increase the number of therapies discovered and then enable those therapies to be more rapidly driven into the clinic. We provide researchers with the pivotal support they need to make critical breakthroughs. We fund novel translational research aimed at finding the fastest possible route to a cure.

Resources

for patients and the community

Watch Video

Be empowered: taking action and pushing for new therapies

Dr. Agus: "Our online video library provides information for patients and families on topics such as clinical trials and personalized medicine."

Research

for researchers and collaboration

ABC2 invests in each stage of the therapeutic development pipeline. Our Pre-Clincial Screening Program breaks down barriers to entry, our Research Grants focuses on novel therapies, and our collaborations with industry allows us to bring the most promising treatments to patients quickly.
 
 

Donate

join us in finding a cure

ABC2 understands that fighting brain cancer is a team effort. We seek to bring together those who care about advancing therapies for patients. Our mission is straightforward: to accelerate the development of treatments that will lead to a cure for brain cancer. In this effort your support plays a key role in getting us there.